Voyager Therapeutics, Inc. - 8-K Filing
Voyager Therapeutics appoints Robin Swartz as President and announces her planned succession as CEO in Q1 2027. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $VYGR